Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lemaitre Vascular Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 291 | 2 | 307 | +18 |
| Shares | 21.0M | 162.6K | 21.2M | +356.4K (+1.7%) |
| Value | $1.95B | $14.8M | $1.95B | +$17.5M (+0.9%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Lemaitre Vascular Inc at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (25)
Institutions that held Lemaitre Vascular Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Norges Bank | 98,278 | $9.13M |
| Jump Financial, LLC | 11,928 | $1.11M |
| Jefferies Financial Group Inc. | 6,417 | $596.1K |
| Summit Global Investments | 6,192 | $575.0K |
| Cresset Asset Management, LLC | 5,701 | $529.6K |
| Everence Capital Management Inc | 5,530 | $514.0K |
| Alpha DNA Investment Management LLC | 5,257 | $488.3K |
| Verition Fund Management LLC | 4,472 | $415.4K |
| Acadian Asset Management LLC | 4,279 | $396.0K |
| XTX Topco Ltd | 3,705 | $344.2K |
| Prelude Capital Management, LLC | 3,472 | $322.5K |
| Quadrature Capital Ltd | 3,020 | $280.8K |
| Keebeck Alpha, LP | 2,690 | $249.9K |
| Petrus Trust Company, LTA | 2,368 | $220.0K |
| Susquehanna Portfolio Strategies, LLC | 2,338 | $217.2K |
| James Investment Research Inc | 2,165 | $201.1K |
| nVerses Capital, LLC | 700 | $65.0K |
| NBC Securities, Inc. | 433 | $40.0K |
| Macroview Investment Management LLC | 137 | $12.7K |
| Ronald Blue Trust, Inc. | 97 | $7.98K |
| Financial Network Wealth Advisors LLC | 67 | $6.22K |
| Capital Performance Advisors LLP | 33 | $3.06K |
| Continuum Advisory, LLC | 8 | $812 |
| Bokf, NA | 6 | $545 |
| Mendota Financial Group, LLC | 1 | $93 |
Not filed for Q4 2024 yet (2)
Institutions that held Lemaitre Vascular Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Scout Investments, Inc. | 132,999 | $12.0M |
| Raymond James & Associates | 29,592 | $2.75M |